Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now full pipeline small index

Rotator Cuff Tear: full-pipeline trial registry

1 of 12 indexed Rotator Cuff Tear trials are currently recruiting.

Corpus placement: #1,429 of 28,707 conditions by registered trial count.

12 US clinical trials · 1 currently recruiting · #1,429 of 28,707 conditions by registered trial count

Rotator Cuff Tear: 12 US clinical trials tracked, 1 recruiting.

Rotator Cuff Tear is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Santa Barbara Cottage Hospital, running 1 of these trials.

Enrollment posture brief

Registry condition rotator-cuff-tear

OPEN 1 | RECR 8% | LATE 3 | EARLY 2 | RANK #1429 | SPON 1

Nearest open-share peer: Allergic Rhinitis (8% recruiting · 24 trials)

Acute Myeloid Leukemia in Re41.7%Adenocarcinoma of the Rectum41.7%Adherence, Patient16.7%Rotator Cuff Tear (this)8%Accelerated Phase Chronic My0%
Open-enrollment share among volume-matched conditions near Rotator Cuff Tear

Rotator Cuff Tear lists 1 open slots (8% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Rotator Cuff Tear on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Rotator Cuff Tear is recruiting below its size-band peers.

    1 of 12 indexed trials (8.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Rotator Cuff Tear trials is spread across many organizations.

    Santa Barbara Cottage Hospital accounts for 1 of 12 trials (8.3%). 12 distinct sponsors appear on at least one study for this condition label.

  3. Most Rotator Cuff Tear trials plan to enrol fewer than 100 people.

    Median target enrolment is 78 among the 12 trials that report a genuine target (sentinel values excluded). 9 of those (75%) plan for fewer than 100 participants.

  4. Rotator Cuff Tear research is mostly interventional.

    11 interventional and 1 observational studies make up this index (91.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 43

Open and recent trials

12 total, page 1 of 1

RECRUITING NA 60 participants

FiberLocker® System Augmentation of Rotator Cuff Repairs

ZuriMED Technologies

NCT06918041

ACTIVE NOT RECRUITING NA 168 participants

Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

InGeneron

NCT03752827

ACTIVE NOT RECRUITING 125 participants

Rotator Cuff Failure With Continuity

The Cleveland Clinic

NCT02716441

ACTIVE NOT RECRUITING NA 116 participants

Oxandrolone Rotator Cuff Trial

University of Southern California

NCT03091075

ACTIVE NOT RECRUITING Phase 2 56 participants

Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears

Hospital for Special Surgery, New York

NCT03332238

COMPLETED Phase 4 97 participants

Rotator Cuff Repair Using Standard Double Row Technique With Platelet Rich Fibrin Membrane vs. Standard Double Row Technique

HealthPartners Institute

NCT02256891

COMPLETED Phase 4 86 participants

Opioid-Free Shoulder Arthroplasty

OrthoCarolina Research Institute

NCT03540030

COMPLETED Phase 4 78 participants

Single Shot Liposomal Bupivicaine in Rotator Cuff Surgery

Indiana University

NCT03822182

COMPLETED NA 71 participants

BioWick SureLock Clinical Outcomes Study

Zimmer Biomet

NCT03199391

COMPLETED Phase 2 70 participants

Nonopioid Analgesia After Rotator Cuff Repair

Henry Ford Health System

NCT03818919

COMPLETED NA 53 participants

Vascular Changes of Rotator Cuff Repair Augmented With a Whole Blood Fibrin Clot

Santa Barbara Cottage Hospital

NCT03577379

COMPLETED NA 51 participants

Regenexx™ SD Versus Exercise Therapy for Rotator Cuff Tears

Regenexx

NCT01788683

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 4 3

Named interventions

Most-linked intervention names on Rotator Cuff Tear records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Gabapentin Drug
2 trials
Celecoxib Drug
2 trials
Double Row Procedure
1 trials
PRFM Device
1 trials
BioWick SureLock Implant Device
1 trials
liposomal bupivicaine Drug
1 trials
Whole Blood Fibrin Clot Other
1 trials
Diazepam Drug
1 trials

US sites by state

Facility locations filed on Rotator Cuff Tear trials. A trial with sites in several states counts in each.

California 4 trials
North Carolina 2 trials
Michigan 2 trials
Florida 2 trials
Arizona 2 trials
Virginia 1 trials
Utah 1 trials
Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Rotator Cuff Tear page

12 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Rotator Cuff Tear condition card totals 12 registered trials; most-linked intervention Gabapentin; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.